about
Application of isothermal helicase-dependent amplification with a disposable detection device in a simple sensitive stool test for toxigenic Clostridium difficileEffect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trialSystematic review: faecal transplantation for the treatment of Clostridium difficile-associated diseaseHost recognition of Clostridium difficile and the innate immune response.Structural Insight into the Clostridium difficile Ethanolamine Utilisation MicrocompartmentEpidemiology and Recurrence Rates of Clostridium difficile Infections in Germany: A Secondary Data Analysis.Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin ASanitary impact evaluation of drinking water in storage reservoirs in Moroccan rural area.Extraction and sensitive detection of toxins A and B from the human pathogen Clostridium difficile in 40 seconds using microwave-accelerated metal-enhanced fluorescence.Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid.Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile Infection: a meta-analysis.Colitis due to Clostridium difficile toxins: underdiagnosed, highly virulent, and nosocomial.Reduction in Clostridium difficile infection rates after mandatory hospital public reporting: findings from a longitudinal cohort study in Canada.Ramoplanin: a lipoglycodepsipeptide antibiotic.Development of TaqMan-based quantitative PCR for sensitive and selective detection of toxigenic Clostridium difficile in human stools.Succession in the gut microbiome following antibiotic and antibody therapies for Clostridium difficile.Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential.Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam.Systematic review of the risk of enteric infection in patients taking acid suppression.Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.Epidemiology of clostridium difficile and vancomycin-resistant Enterococcus colonization in patients on a spinal cord injury unitIndeterminate tcdB using a Clostridium difficile PCR assay: a retrospective cohort studyThe identification and epidemiology of meticillin-resistant Staphylococcus aureus and Clostridium difficile in patient rooms and the ward environment.Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection.Appendectomy and Clostridium difficile colitis: relationships revealed by clinical observations and immunology.An in vitro culture model to study the dynamics of colonic microbiota in Syrian golden hamsters and their susceptibility to infection with Clostridium difficileAre broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapyClostridium difficile-associated diarrhea after living donor liver transplantation.Prevalence and molecular characterization of Clostridium difficile isolated from European Barn Swallows (Hirundo rustica) during migration.Discovery of selective inhibitors of the Clostridium difficile dehydroquinate dehydrataseClostridium difficile: a formidable foe.First report of Clostridium difficile NAP1/027 in a Mexican hospitalFecal microbiota transplantation for Clostridium difficile infection: back to the future.Aging of the human metaorganism: the microbial counterpartPredictors and outcomes of readmission for Clostridium difficile in a national sample of medicare beneficiariesClostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection.Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis
P2860
Q24642390-FDF8314C-DF45-4CDF-809F-AD3EEECE7329Q24655137-EE8CB8E0-F200-41C6-B76D-C0A5EED4F48AQ26851409-26853E8C-8589-4EB9-94C2-4C7594A0D245Q27026464-CCD48885-3A8D-4D8C-AA1D-4D303A66B023Q27675090-68167EC0-2899-4038-AA6A-29BDD7034066Q31138398-C18D5AC9-931C-4D3D-A04A-F7CFC333FC6FQ33214954-A33FE878-B8EA-4ED7-91E7-F4B01629EA90Q33475206-DAF19CC7-B86D-488A-8786-F5240F4B8461Q33632679-30935AC0-DDAC-4E00-8605-4F94A81B869FQ34097036-9B8B21A1-D89B-4781-AE51-8F34D3FB35F1Q34150754-B5D9B16E-ED79-458D-A15E-609BE3D495FEQ34213457-E839F8D6-A9AF-4FCD-B87C-4B38C578C964Q34249194-6A352878-33D2-4054-A0D0-76D5B31F5CE7Q34289281-EF1BC22C-F925-4913-9F59-24C2A00150D6Q34405651-4469EAFA-006C-4EDF-B3F0-BF171716890BQ34435291-0D9059B0-9F7A-4BEB-B098-B53F5CC6BCA6Q34447678-3B8EDC00-F786-457B-85C4-5F1B9DFFB748Q34557101-BB03EE2C-0533-4E14-8AFC-C2363861DF3CQ34626378-AAB28A0C-E2C8-40BB-A093-D860C1745501Q34629190-3832E0D2-B172-489B-9A22-A90040761443Q34690415-7E1A6D0D-B2B1-44B6-9D52-3AC8DFBCCB33Q34734495-C9979596-F024-4850-AB2B-4F99530EC33CQ34832564-1D0770E1-E191-49CB-9600-4762DA80AFDDQ34862890-4F495E9F-617A-480A-9C94-876900FB51B9Q34889940-8BB5A162-F2F4-4F45-B936-DED6A2E746BDQ34987921-6CD3B42A-4977-4694-8381-1D52E01B0809Q35002637-9C7D57BB-9794-4934-B9DB-4BDC3D675D52Q35023239-978A69A4-4F32-4A15-88C0-C3C257085FEAQ35039058-BE9C0ACD-1B59-475E-89E4-40F6CE136250Q35055941-751B5A12-B065-498F-B8B9-216E14E7AD6CQ35089214-FDFEF9EF-E8AF-4E29-B16D-2E3CB49B3F5BQ35107124-A2565F7F-B94E-4BD1-9762-BD3C4CCF573DQ35225161-D98DC16E-286E-43F5-A1E0-D643D4D0ACF6Q35542708-71F39E91-7D30-4905-9209-470E18B0F37EQ35660581-1C4541ED-A771-42E3-805A-8A26DE5F606CQ35678151-ACB432F9-D421-45FE-92DD-BE24644A83E5Q35711361-8485A204-6DD3-46FD-9496-7FB3D0D8B71FQ35874779-A8F32BDB-351C-4BF6-89C8-D96ACDAE1C96Q35930922-6B0766E1-DC83-488E-9822-2716E089D9A3Q36116938-746AC7EC-C8A3-4749-AC1E-58C9F053E09A
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Clostridium difficile-associated diarrhea in adults
@ast
Clostridium difficile-associated diarrhea in adults
@en
type
label
Clostridium difficile-associated diarrhea in adults
@ast
Clostridium difficile-associated diarrhea in adults
@en
prefLabel
Clostridium difficile-associated diarrhea in adults
@ast
Clostridium difficile-associated diarrhea in adults
@en
P2860
P356
P1476
Clostridium difficile-associated diarrhea in adults
@en
P2093
Andrew E Simor
P2860
P356
10.1503/CMAJ.1031189
P407
P577
2004-07-01T00:00:00Z